{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:25:12Z","timestamp":1792401912293,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.mayocp.2019.04.027","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T08:05:18Z","timestamp":1571126718000},"page":"2524-2533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Sea Change for Marine Omega-3s"],"prefix":"10.1016","volume":"94","author":[{"given":"Evan L.","family":"O'Keefe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7888-1528","authenticated-orcid":false,"given":"James J.","family":"DiNicolantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Elagizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard V.","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3906-1911","authenticated-orcid":false,"given":"Carl J.","family":"Lavie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3376-5822","authenticated-orcid":false,"given":"James H.","family":"O'Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7710","key":"10.1016\/j.mayocp.2019.04.027_bib1","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0140-6736(71)91658-8","article-title":"Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos","volume":"1","author":"Bang","year":"1971","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mayocp.2019.04.027_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.mayocp.2019.04.027_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1811403","article-title":"Marine n-3 fatty acids and prevention of cardiovascular disease and cancer","volume":"380","author":"Manson","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.mayocp.2019.04.027_bib4","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJMoa1804989","article-title":"Effects of n-3 fatty acid supplements in diabetes mellitus","volume":"379","author":"Bowman","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.mayocp.2019.04.027_bib5","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"25","key":"10.1016\/j.mayocp.2019.04.027_bib6","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"373","author":"Cannon","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.mayocp.2019.04.027_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1300955","article-title":"Effects of extended-release niacin with laropiprant in high-risk patients","volume":"371","author":"Landray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.mayocp.2019.04.027_bib8","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Boden","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.mayocp.2019.04.027_bib9","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.mayocp.2019.04.027_bib10","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.mayocp.2019.04.027_bib11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jacc.2018.10.039","article-title":"Alirocumab reduces total nonfatal cardiovascular and fatal events in the ODYSSEY OUTCOMES trial","volume":"73","author":"Szarek","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.mayocp.2019.04.027_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular cutcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mayocp.2019.04.027_bib13","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mayocp.2019.04.027_bib14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ahj.2017.02.021","volume":"187","author":"Bowman","year":"2017","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.mayocp.2019.04.027_bib15","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.18632\/oncotarget.23783","article-title":"A\u00a0meta-analysis on omega-3 supplements in preventing recurrence of atrial fibrillation","volume":"9","author":"Jiang","year":"2018","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.mayocp.2019.04.027_bib16","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","article-title":"Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology","volume":"118","author":"Nordestgaard","year":"2016","journal-title":"Circ Res"},{"issue":"8","key":"10.1016\/j.mayocp.2019.04.027_bib17","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1210\/jc.2018-00470","article-title":"Increased cardiovascular risk in hypertriglyceridemic patients with statin-controlled LDL cholesterol","volume":"103","author":"Nichols","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.mayocp.2019.04.027_bib18","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jacc.2018.04.061","article-title":"Unmet need for adjunctive dyslipidemia therapy in hypertriglyceridemia management","volume":"72","author":"Ganda","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.mayocp.2019.04.027_bib19","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.jacc.2013.01.082","article-title":"Niacin therapy lives for another day\u2013maybe?","volume":"61","author":"Lavie","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.mayocp.2019.04.027_bib20","first-page":"CD009580","article-title":"Fibrates for secondary prevention of cardiovascular disease and stroke","volume":"10","author":"Wang","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.mayocp.2019.04.027_bib21","first-page":"464","article-title":"The microvascular and macrovascular benefits of fibrates in diabetes and the metabolic syndrome: a review","volume":"114","author":"Malur","year":"2017","journal-title":"Mo Med"},{"issue":"2","key":"10.1016\/j.mayocp.2019.04.027_bib22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3945\/ajcn.110.003871","article-title":"Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia","volume":"93","author":"Skulas-Ray","year":"2011","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.mayocp.2019.04.027_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.clinthera.2017.11.007","article-title":"Efficacy and safety of adding omega-3 fatty acids in statin-treated patients with residual hypertriglyceridemia: ROMANTIC (Rosuvastatin-OMAcor iN residual hyperTrIglyCeridemia), a randomized, double-blind, and placebo-controlled trial","volume":"40","author":"Kim","year":"2018","journal-title":"Clin Ther"},{"issue":"20","key":"10.1016\/j.mayocp.2019.04.027_bib24","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.mayocp.2019.04.027_bib25","doi-asserted-by":"crossref","first-page":"e000946","DOI":"10.1136\/openhrt-2018-000946","article-title":"Importance of maintaining a low omega-6\/omega-3 ratio for reducing inflammation","volume":"5","author":"DiNicolantonio","year":"2018","journal-title":"Open Heart"},{"issue":"11","key":"10.1016\/j.mayocp.2019.04.027_bib26","doi-asserted-by":"crossref","first-page":"e004584","DOI":"10.1161\/CIRCOUTCOMES.118.004584","article-title":"Fish oil and perioperative bleeding: insights from the OPERA randomized trial","volume":"11","author":"Akintoye","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"6A","key":"10.1016\/j.mayocp.2019.04.027_bib27","doi-asserted-by":"crossref","first-page":"44C","DOI":"10.1016\/j.amjcard.2006.11.021","article-title":"Expert opinion: omega-3 fatty acids and bleeding-cause for concern?","volume":"99","author":"Harris","year":"2007","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.mayocp.2019.04.027_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mayocp.2016.10.018","article-title":"A\u00a0meta-analysis of randomized controlled trials and prospective cohort studies of eicosapentaenoic and docosahexaenoic long-chain omega-3 fatty acids and coronary heart disease risk","volume":"92","author":"Alexander","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"8666","key":"10.1016\/j.mayocp.2019.04.027_bib29","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(89)90828-3","article-title":"Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART)","volume":"2","author":"Burr","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.mayocp.2019.04.027_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2017.05.007","article-title":"The Omega-3 Index and relative risk for coronary heart disease mortality: estimation from 10 cohort studies","volume":"262","author":"Harris","year":"2017","journal-title":"Atherosclerosis"},{"issue":"9645","key":"10.1016\/j.mayocp.2019.04.027_bib31","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(08)61239-8","article-title":"Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Tavazzi","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mayocp.2019.04.027_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mayocp.2016.11.008","article-title":"Omega-3 fatty acid therapy: the tide turns for a fish story","volume":"92","author":"O'Keefe","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.mayocp.2019.04.027_bib33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jamacardio.2017.5205","article-title":"Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: meta-analysis of 10 trials involving 77,917 individuals","volume":"3","author":"Aung","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"8","key":"10.1016\/j.mayocp.2019.04.027_bib34","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/jamainternmed.2016.2925","article-title":"Omega-3 polyunsaturated fatty acid biomarkers and coronary heart disease: pooling project of 19 cohort studies","volume":"176","author":"Del Gobbo","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"15","key":"10.1016\/j.mayocp.2019.04.027_bib35","doi-asserted-by":"crossref","first-page":"e867","DOI":"10.1161\/CIR.0000000000000482","article-title":"Omega-3 polyunsaturated fatty acid (fish oil) supplementation and the prevention of clinical cardiovascular disease: a science advisory from the American Heart Association","volume":"135","author":"Siscovick","year":"2017","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.mayocp.2019.04.027_bib36","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.amjcard.2005.11.025","article-title":"Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions","volume":"97","author":"O'Keefe","year":"2006","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.mayocp.2019.04.027_bib37","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ypmed.2004.02.030","article-title":"The Omega-3 Index: a new risk factor for death from coronary heart disease?","volume":"39","author":"Harris","year":"2004","journal-title":"Prev Med"},{"issue":"12","key":"10.1016\/j.mayocp.2019.04.027_bib38","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1161\/01.CIR.0000142292.10048.B2","article-title":"Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation","volume":"110","author":"Harris","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.mayocp.2019.04.027_bib39","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3945\/ajcn.2009.28302","article-title":"Relation between blood and atrial fatty acids in patients undergoing cardiac bypass surgery","volume":"91","author":"Metcalf","year":"2010","journal-title":"Am J Clin Nutr"},{"issue":"9177","key":"10.1016\/j.mayocp.2019.04.027_bib40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(99)07072-5","article-title":"Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo studio della Sopravvivenza nell\u2019infarto miocardico","volume":"354","year":"1999","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.mayocp.2019.04.027_bib41","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/ajcn\/nqz161","article-title":"Predicting the effects of supplemental EPA and DHA on the omega-3 index","volume":"110","author":"Walker","year":"2019","journal-title":"Am J Clin Nutr"},{"issue":"9567","key":"10.1016\/j.mayocp.2019.04.027_bib42","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(07)60527-3","article-title":"Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis","volume":"369","author":"Yokoyama","year":"2007","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.mayocp.2019.04.027_bib43","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1161\/CIRCULATIONAHA.115.019949","article-title":"Effect of omega-3 acid ethyl esters on left ventricular remodeling after acute myocardial infarction: the OMEGA-REMODEL randomized clinical trial","volume":"134","author":"Heydari","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.mayocp.2019.04.027_bib44","first-page":"CD003402","article-title":"Omega-3 fatty acid addition during pregnancy","volume":"11","author":"Middleton","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.mayocp.2019.04.027_bib45","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1161\/CIR.0000000000000574","article-title":"Seafood long-chain n-3 polyunsaturated fatty acids and cardiovascular disease: a science advisory from the American Heart Association","volume":"138","author":"Rimm","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.mayocp.2019.04.027_bib46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3945\/ajcn.115.114322","article-title":"Interaction of \u03c9-3 fatty acids with B vitamins in slowing the progression of brain atrophy: identifying the elderly at risk","volume":"102","author":"Blasko","year":"2015","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.mayocp.2019.04.027_bib47","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.biopha.2018.04.118","article-title":"Eicosapentaenoic acid improves endothelial function and nitric oxide bioavailability in a manner that is enhanced in combination with a statin","volume":"103","author":"Mason","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"10.1016\/j.mayocp.2019.04.027_bib48","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.healun.2006.03.005","article-title":"Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure","volume":"25","author":"Mehra","year":"2006","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"21","key":"10.1016\/j.mayocp.2019.04.027_bib49","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000038493.65177.94","article-title":"Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease","volume":"106","author":"Kris-Etherton","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.mayocp.2019.04.027_bib50","series-title":"2015-2020 Dietary Guidelines for Americans","author":"Millen","year":"2015"},{"issue":"2","key":"10.1016\/j.mayocp.2019.04.027_bib51","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11745-014-3968-6","article-title":"n-3 PUFA esterified to glycerol or as ethyl esters reduce non-fasting plasma triacylglycerol in subjects with hypertriglyceridemia: a randomized trial","volume":"50","author":"Hedengran","year":"2015","journal-title":"Lipids"},{"issue":"1","key":"10.1016\/j.mayocp.2019.04.027_bib52","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bbrc.2016.12.127","article-title":"Omega-3 fatty acid fish oil dietary supplements contain saturated fats and oxidized lipids that may interfere with their intended biological benefits","volume":"483","author":"Mason","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"10.1016\/j.mayocp.2019.04.027_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41387-017-0007-8","article-title":"Comparison of the effect of omega-3 supplements and fresh fish on lipid profile: a randomized, open-labeled trial","volume":"7","author":"Zibaeenezhad","year":"2017","journal-title":"Nutr Diabetes"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619304112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619304112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:31:17Z","timestamp":1758418277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619619304112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":53,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0025619619304112"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.04.027","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sea Change for Marine Omega-3s","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.04.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}